Pharmacologic prophylaxis alone is not adequate to prevent post-ERCP pancreatitis

Mustafa A Arain, Martin L Freeman

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Post-ERCP pancreatitis (PEP) remains the most common complication following ERCP. Although once considered unpredictable, understanding patient and procedure-related risk factors, and measures such as pancreatic stent placement and pharmacoprophylaxis have been shown to substantially decrease the risk of PEP. In this issue of the Journal, the role of pharmacoprophylaxis is explored in a study comparing rectal indomethacin plus sublingual nitrates vs. rectal indomethacin alone. While showing improved efficacy, dual pharmacoprophylaxis does not appear adequate to obviate the importance of technique-related variables and pancreatic stents. Rather, a comprehensive approach is likely to be the most efficacious strategy to reduce PEP.

Original languageEnglish (US)
Pages (from-to)910-912
Number of pages3
JournalAmerican Journal of Gastroenterology
Issue number6
StatePublished - Jun 2014


Dive into the research topics of 'Pharmacologic prophylaxis alone is not adequate to prevent post-ERCP pancreatitis'. Together they form a unique fingerprint.

Cite this